Catalyst Wire Dossier Catalyst Wire Dossier

LDX (lisdexamfetamine dimesylate)

lisdexamfetamine dimesylate · Takeda Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LDX (lisdexamfetamine dimesylate), covering 2017-07-11 to 2017-07-11. Get the full timeline:

Most recent: Clinical Trial Update: LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women [Phase 4]

See pricing